QTc prolongation assessment in anticancer drug development: clinical and methodological issues

Cardiac safety assessments are commonly employed in the clinical development of investigational oncology medications. In anti-cancer drug development there has been increasing consideration for the potential of a compound to cause adverse electrocardiographic changes, especially QT interval prolonga...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Curigliano, G, Spitaleri, G, de Braud, F, Cardinale, D, Cipolla, C, Civelli, M, Colombo, N, Colombo, A, Locatelli, M, Goldhirsch, A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cancer Intelligence 2009
Gaiak:
Reviews
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223992/
https://ncbi.nlm.nih.gov/pubmed/22275999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2009.130
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak